Eli Lilly and Incyte's Olumiant has secured the first FDA approval for a systemic drug to treat alopecia areata, an autoimmune condition causing patchy hair loss that affects more than 700,000 ...

Eli Lilly and Incyte have another rival in the rear-view mirror for Olumiant in alopecia areata after Pfizer reported that its ritlecitinib improved scalp hair regrowth in a late-stage trial.

In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis ...

WAYNE, Pa. - Aclaris Therapeutics, Inc. (NASDAQ: NASDAQ:ACRS), a clinical-stage biopharmaceutical company with a market ...

Pre-Market: 6:33:49 a.m. EST ...

After hours: 7:59:35 pm GMT-5 ...

After hours: 31 January at 19:59:23 GMT-5 Loading Chart for LLY ...

Feb. 20, 2024 — The drug finasteride, also known as Propecia or Proscar, treats male pattern baldness and enlarged prostate in millions of men worldwide. But a new study suggests the drug may ...